2026-10-02 Sumitomo Pharma Co.,Ltd. “Regenerative medicine aimed at restoring function in patients with "pituitary insufficiency."”
2026-10-02 Sumitomo Pharma Co.,Ltd. “Regenerative medicine aimed at restoring function in patients with … 続きを読む
JP3495000006
2026-09-30 Sumitomo Pharma Co.,Ltd. “Preliminary report on the final analysis results of the European Phase 1 trial of a novel universal influenza vaccine candidate using a novel TLR7 vaccine adjuvant (DSP-0546) created by Sumitomo Pharma.”
2026-09-30 Sumitomo Pharma Co.,Ltd. “Preliminary report on the final analysis results of the European Ph … 続きを読む
2026-08-31 Sumitomo Pharma Co.,Ltd. “It was selected as one of the five constituent stocks of the ESG investment index adopted by GPIF.”
2026-08-31 Sumitomo Pharma Co.,Ltd. “It was selected as one of the five constituent stocks of the ESG in … 続きを読む
2026-08-28 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Recognition of Retirement Benefit Trust Return Gain (Extraordinary Income) in Our Individual Financial Statements (Japanese GAAP).”
2026-08-28 Sumitomo Pharma Co.,Ltd. “Notice Regarding the Recognition of Retirement Benefit Trust Return … 続きを読む
2026-08-26 Sumitomo Pharma Co.,Ltd. “Announcement regarding the selection of stocks to be included in the "JPX Prime 150 Index".”
2026-08-26 Sumitomo Pharma Co.,Ltd. “Announcement regarding the selection of stocks to be included in th … 続きを読む
2026-08-21 Sumitomo Pharma Co.,Ltd. “Materials from the President's press conference and press briefing (held on August 21, 2026) are posted here.”
2026-08-21 Sumitomo Pharma Co.,Ltd. “Materials from the President's press conference and press brief … 続きを読む
2026-08-13 Sumitomo Pharma Co.,Ltd. “Announcement of the first transplant to a subject in the Phase 1/2 trial of "Retinitis Pigmentosa Treatment using Allogeneic iPS Cell-Derived Retinal Sheet (3D Retina)" in the United States.”
2026-08-13 Sumitomo Pharma Co.,Ltd. “Announcement of the first transplant to a subject in the Phase 1/2 … 続きを読む
2026-08-12 Sumitomo Pharma Co.,Ltd. “Regarding the report concerning our company (our response to "Sumitomo Chemical and Sumitomo Pharmaceutical: Part II – CiRA, Dr. Yamanaka, and the undisclosed history of image duplication concerns").”
2026-08-12 Sumitomo Pharma Co.,Ltd. “Regarding the report concerning our company (our response to " … 続きを読む
2026-08-07 Sumitomo Pharma Co.,Ltd. “Regarding the report about our company (additional explanation regarding "Sumitomo Chemical and Sumitomo Pharmaceutical: The ¥116 Billion Swiss Shuffle").”
2026-08-07 Sumitomo Pharma Co.,Ltd. “Regarding the report about our company (additional explanation rega … 続きを読む
2026-07-31 Sumitomo Pharma Co.,Ltd. “Financial Statements for the First Quarter of 2027 (IFRS) (link).”
2026-07-31 Sumitomo Pharma Co.,Ltd. “Financial Statements for the First Quarter of 2027 (IFRS) (link).&# … 続きを読む